
Taylor A. Elfervig
Examiner (ID: 2499, Phone: (571)270-5687 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | 2445 |
| Total Applications | 462 |
| Issued Applications | 261 |
| Pending Applications | 64 |
| Abandoned Applications | 154 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11497732
[patent_doc_number] => 20170071917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA'
[patent_app_type] => utility
[patent_app_number] => 15/343690
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22553
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343690
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343690 | Methods of treatment Rett syndrome | Nov 3, 2016 | Issued |
Array
(
[id] => 11678203
[patent_doc_number] => 09676718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Piperidine compounds, pharmaceutical composition comprising the same and its use'
[patent_app_type] => utility
[patent_app_number] => 15/248872
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29559
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15248872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/248872 | Piperidine compounds, pharmaceutical composition comprising the same and its use | Aug 25, 2016 | Issued |
Array
(
[id] => 11914212
[patent_doc_number] => 09782385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Artificial tears solution combination'
[patent_app_type] => utility
[patent_app_number] => 15/142428
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4490
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/142428 | Artificial tears solution combination | Apr 28, 2016 | Issued |
Array
(
[id] => 11879561
[patent_doc_number] => 09750716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Compounds and forms of treatment for female sexual disorders'
[patent_app_type] => utility
[patent_app_number] => 15/074984
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 28190
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/074984 | Compounds and forms of treatment for female sexual disorders | Mar 17, 2016 | Issued |
Array
(
[id] => 11067580
[patent_doc_number] => 20160264544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'Tetrahydrothiophene-based GABA Aminotransferase Inactivators'
[patent_app_type] => utility
[patent_app_number] => 15/065487
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13678
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065487
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065487 | Tetrahydrothiophene-based GABA aminotransferase inactivators | Mar 8, 2016 | Issued |
Array
(
[id] => 10978339
[patent_doc_number] => 20160175282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'SPHINGOSINE 1 PHOSPHATE RECEPTOR MODUATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 15/054888
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5914
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054888
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054888 | SPHINGOSINE 1 PHOSPHATE RECEPTOR MODUATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION | Feb 25, 2016 | Abandoned |
Array
(
[id] => 11873553
[patent_doc_number] => 09745310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 15/053569
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35502
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15053569
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/053569 | Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same | Feb 24, 2016 | Issued |
Array
(
[id] => 11872384
[patent_doc_number] => 09744133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Enhanced stability of novel liquid compositions'
[patent_app_type] => utility
[patent_app_number] => 15/015483
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8196
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015483
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015483 | Enhanced stability of novel liquid compositions | Feb 3, 2016 | Issued |
Array
(
[id] => 11929682
[patent_doc_number] => 09796664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/993621
[patent_app_country] => US
[patent_app_date] => 2016-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 53661
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14993621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/993621 | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors | Jan 11, 2016 | Issued |
Array
(
[id] => 10997376
[patent_doc_number] => 20160194320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/990680
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51119
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990680
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990680 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | Jan 6, 2016 | Abandoned |
Array
(
[id] => 10988757
[patent_doc_number] => 20160185703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/984442
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6945
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14984442
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/984442 | Compounds from antrodia camphorata, method for preparing the same and use thereof | Dec 29, 2015 | Issued |
Array
(
[id] => 10737179
[patent_doc_number] => 20160083329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'PREPARATION METHOD OF 1-PALMITOYL-3-ACETYLGLYCEROL, AND PREPARATION METHOD OF 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/958734
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3713
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14958734
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/958734 | Preparation method of 1-palmitoyl-3-acetylglycerol, and preparation method of 1-palmitoyl-2-linoleoyl-3-acetylglycerol using same | Dec 2, 2015 | Issued |
Array
(
[id] => 10799117
[patent_doc_number] => 20160145272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'TRIAZOLO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 14/945576
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43799
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945576 | Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators | Nov 18, 2015 | Issued |
Array
(
[id] => 10799117
[patent_doc_number] => 20160145272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'TRIAZOLO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 14/945576
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43799
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945576 | Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators | Nov 18, 2015 | Issued |
Array
(
[id] => 11684058
[patent_doc_number] => 09682090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Methods for treating and preventing prostate cancer bone metastases'
[patent_app_type] => utility
[patent_app_number] => 14/941281
[patent_app_country] => US
[patent_app_date] => 2015-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 8955
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14941281
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/941281 | Methods for treating and preventing prostate cancer bone metastases | Nov 12, 2015 | Issued |
Array
(
[id] => 11893953
[patent_doc_number] => 09763870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Formulation comprising liquid ester quats and/or imidazolinium salts and polymer thickeners'
[patent_app_type] => utility
[patent_app_number] => 14/861380
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10471
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861380
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/861380 | Formulation comprising liquid ester quats and/or imidazolinium salts and polymer thickeners | Sep 21, 2015 | Issued |
Array
(
[id] => 11596812
[patent_doc_number] => 09643965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Histone demethylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/855950
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44324
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855950
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/855950 | Histone demethylase inhibitors | Sep 15, 2015 | Issued |
Array
(
[id] => 11635060
[patent_doc_number] => 09657016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => '3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/847299
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61961
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14847299
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/847299 | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof | Sep 7, 2015 | Issued |
Array
(
[id] => 11872642
[patent_doc_number] => 09744391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Use of metal-accumulating plants for implementing chemical reactions'
[patent_app_type] => utility
[patent_app_number] => 14/831987
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 22056
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831987
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831987 | Use of metal-accumulating plants for implementing chemical reactions | Aug 20, 2015 | Issued |
Array
(
[id] => 10705422
[patent_doc_number] => 20160051569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'Methods for Inhibiting the Development, Formation and/or Maturation of Bacterial and Fungal Biofilms'
[patent_app_type] => utility
[patent_app_number] => 14/831695
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2053
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831695
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831695 | Methods for Inhibiting the Development, Formation and/or Maturation of Bacterial and Fungal Biofilms | Aug 19, 2015 | Abandoned |